Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Enabling parallel protein analysis through mass spectrometry.

Bruno Domon, Kim Alving, Tao He

    Current Opinion in Molecular Therapeutics
    |February 25, 2003
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Clinical validation of an AI-based pathology tool for scoring of metabolic dysfunction-associated steatohepatitis.

    Nature medicine·2024
    Same author

    AI-based automation of enrollment criteria and endpoint assessment in clinical trials in liver diseases.

    Nature medicine·2024
    Same author

    Decoding disease: Scott Patterson's perspectives on the power of biomarkers in drug development.

    BioTechniques·2023
    Same author

    RNA-seq RNAaccess identified as the preferred method for gene expression analysis of low quality FFPE samples.

    PloS one·2023
    Same author

    Wild-Type <i>KRAS</i> Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
    Same author

    Remdesivir improves biomarkers associated with disease severity in COVID-19 patients treated in an outpatient setting.

    Communications medicine·2023
    Same journal

    Gene therapy: Have the risks associated with viral vectors been solved?

    Current opinion in molecular therapeutics·2011
    Same journal

    Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.

    Current opinion in molecular therapeutics·2010
    Same journal

    Dulaglutide, a long-acting GLP-1 analog fused with an Fc antibody fragment for the potential treatment of type 2 diabetes.

    Current opinion in molecular therapeutics·2010
    Same journal

    Corticorelin, a synthetic human corticotropin-releasing factor analog, for the treatment of peritumoral brain edema.

    Current opinion in molecular therapeutics·2010
    Same journal

    Mogamulizumab, a humanized mAb against C-C chemokine receptor 4 for the potential treatment of T-cell lymphomas and asthma.

    Current opinion in molecular therapeutics·2010
    Same journal

    Gevokizumab, an anti-IL-1β mAb for the potential treatment of type 1 and 2 diabetes, rheumatoid arthritis and cardiovascular disease.

    Current opinion in molecular therapeutics·2010
    See all related articles

    Drug discovery relies on analyzing proteins, the targets of most medicines. Recent advances in mass spectrometry (MS) technology are improving parallel protein analysis, crucial for identifying new therapeutic targets.

    Area of Science:

    • Biochemistry and Molecular Biology
    • Analytical Chemistry
    • Pharmacology

    Background:

    • Proteins are the primary targets for most drugs currently in development and on the market.
    • Efficient protein analysis is essential for identifying and validating therapeutic targets.
    • Mass spectrometry is the leading technology for high-throughput protein analysis, also known as proteomics.

    Purpose of the Study:

    • To review recent advancements in mass spectrometry instrumentation.
    • To discuss new mass spectrometry methods relevant to drug discovery.
    • To highlight emerging applications of mass spectrometry in identifying therapeutic targets.

    Main Methods:

    • Review of recent literature on mass spectrometry.
    • Analysis of current trends in mass spectrometry instrumentation and methodologies.

    Related Experiment Videos

  • Examination of case studies in drug discovery utilizing mass spectrometry.

    • Main Results:

    • Significant improvements in mass spectrometry instrumentation offer enhanced sensitivity and throughput.
    • Novel mass spectrometry methods enable more comprehensive proteomic analyses.
    • Emerging applications demonstrate the impact of mass spectrometry on accelerating drug discovery pipelines.

    Conclusions:

    • Advancements in mass spectrometry are poised to significantly impact the future of drug discovery.
    • The continued evolution of mass spectrometry technology will enhance the identification of novel therapeutic targets.
    • Proteomics, powered by mass spectrometry, is a critical field for developing next-generation therapeutics.